(ADVM) Adverum - Performance -67.4% in 12m
ADVM performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-89.40%
#178 in Peer-Group
Rel. Strength
5.23%
#7262 in Stock-Universe
Total Return 12m
-67.39%
#155 in Peer-Group
Total Return 5y
-98.61%
#178 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 9.48 USD |
| 52 Week Low | 2.05 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 81.54 |
| Buy/Sell Signal +-5 | -1.53 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ADVM (-67.4%) vs XBI (-11.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.02% | 61.8% | 74.7% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.89% | -8.76% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.19% | -6.24% | 38% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-2.29% | 26.9% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.48% | -8.9% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
11.5% | 27.6% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.47% | 46.2% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.64% | 26.9% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ADVM vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ADVM
| Total Return (including Dividends) | ADVM | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -1.93% | 3.15% | 4.01% |
| 3 Months | -25.95% | 17.08% | 17.14% |
| 12 Months | -67.39% | -11.14% | 13.46% |
| 5 Years | -98.61% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | ADVM | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -9.8% | 52.1% | 90.3% |
| 3 Months | -55.5% | 79.4% | 97.5% |
| 12 Months | -91.4% | -87.4% | 46.4% |
| 5 Years | -85.6% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th43.50 | -4.93% | -5.71% |
| 3 Month | %th7.00 | -36.75% | -36.78% |
| 12 Month | %th23.00 | -63.31% | -71.26% |
| 5 Years | %th11.00 | -98.22% | -99.35% |
FAQs
Does Adverum (ADVM) outperform the market?
No,
over the last 12 months ADVM made -67.39%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.14%.
Over the last 3 months ADVM made -25.95%, while XBI made 17.08%.
Performance Comparison ADVM vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ADVM vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 13.4% | -5.9% | -47.4% | -81% |
| US NASDAQ 100 | QQQ | 13.5% | -6.1% | -49.4% | -81% |
| German DAX 40 | DAX | 13.1% | -3.2% | -59.5% | -98% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 12.2% | -6.5% | -51.9% | -86% |
| Hongkong Hang Seng | HSI | 12.5% | -4.8% | -69.4% | -102% |
| India NIFTY 50 | INDA | 14.8% | -1.1% | -47.9% | -65% |
| Brasil Bovespa | EWZ | 17.6% | -1.3% | -62.5% | -69% |
ADVM vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 14.8% | -3.6% | -50.7% | -91% |
| Consumer Discretionary | XLY | 12.5% | -5.3% | -39.7% | -86% |
| Consumer Staples | XLP | 15.5% | -1.8% | -46.5% | -75% |
| Energy | XLE | 10.5% | -6.1% | -39.9% | -69% |
| Financial | XLF | 14.9% | -4.6% | -49.7% | -93% |
| Health Care | XLV | 13.3% | -2% | -35.9% | -61% |
| Industrial | XLI | 13% | -6.4% | -53.3% | -91% |
| Materials | XLB | 12.8% | -6.4% | -48.1% | -72% |
| Real Estate | XLRE | 13.7% | -1.8% | -45.9% | -76% |
| Technology | XLK | 13.5% | -8.6% | -52.5% | -79% |
| Utilities | XLU | 13.4% | -4.5% | -51.5% | -87% |
| Aerospace & Defense | XAR | 12.8% | -8.8% | -67.4% | -116% |
| Biotech | XBI | 9.8% | -5.1% | -37.2% | -56% |
| Homebuilder | XHB | 10.4% | -10.7% | -40.8% | -66% |
| Retail | XRT | 13.5% | -5.2% | -42.6% | -74% |
ADVM vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 12.8% | -5.23% | -33.5% | -63% |
| Natural Gas | UNG | 15.2% | 4.5% | -21.4% | -65% |
| Gold | GLD | 13.3% | -2.2% | -65.3% | -106% |
| Silver | SLV | 9.1% | -8.2% | -69.5% | -90% |
| Copper | CPER | 3.1% | -16.9% | -67% | -91% |
ADVM vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 14.3% | -1.9% | -42.1% | -63% |
| iShares High Yield Corp. Bond | HYG | 14% | -3.1% | -44.4% | -76% |